GLABF (Gemina Laboratories) Retained Earnings: $-15.98 Mil (As of Oct. 2025)


What is Gemina Laboratories Retained Earnings?

Gemina Laboratories GLABF -27.59% Retained Earnings is $-15.98 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Gemina Laboratories's retained earnings for the quarter that ended in Oct. 2025 was $-15.98 Mil.

Gemina Laboratories's quarterly retained earnings declined from Apr. 2025 ($-15.45 Mil) to Jul. 2025 ($-16.08 Mil) but then increased from Jul. 2025 ($-16.08 Mil) to Oct. 2025 ($-15.98 Mil).

Gemina Laboratories's annual retained earnings declined from Jan. 2023 ($-8.60 Mil) to Jan. 2024 ($-12.49 Mil) and declined from Jan. 2024 ($-12.49 Mil) to Jan. 2025 ($-14.48 Mil).


Gemina Laboratories  (OTCPK:GLABF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Gemina Laboratories Retained Earnings Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Retained Earnings Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Retained Earnings
-0.66 -4.41 -8.60 -12.49 -14.48

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.12 -14.48 -15.45 -16.08 -15.98

Gemina Laboratories Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-15.98 Mil mean?
Gemina Laboratories (GLABF) has a Retained Earnings of $-15.98 Mil as of Oct. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Retained Earnings too high?
Gemina Laboratories' current Retained Earnings is $-15.98 Mil.
How does Gemina Laboratories' Retained Earnings compare to VRTX and REGN?
Gemina Laboratories' Retained Earnings of $-15.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Retained Earnings is $-15.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Retained Earnings of $-15.98 Mil. The current Retained Earnings is $-15.98 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Retained Earnings is $-15.98 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.